Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001562180-25-004681

CFO AND TREASURER sold 12,000 shares at an average $325.37 ($3,904,496)

  • CFO AND TREASURER acquired 12,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-09 Exercise or conversion : show line 1 in the form 10b5-1 +12,000 $117.76 $1,413,120 20,118 D
2025-06-09 Sale : show line 2 in the form 10b5-1 −3,595 $325.44 $1,169,955 16,523 D
2025-06-09 Sale : show line 3 in the form 10b5-1 −305 $326.56 $99,602 16,218 D
2025-06-09 Sale : show line 4 in the form 10b5-1 −100 $328.28 $32,828 16,118 D
2025-06-09 Sale : show line 5 in the form 10b5-1 −7,700 $325.20 $2,504,068 8,418 D
2025-06-09 Sale : show line 6 in the form 10b5-1 −300 $326.81 $98,042 8,118 D
Open-market sales · 12,000 sh · avg $325.37 · $3,904,496

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-06-09 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option −12,000 $117.76 2027-03-15 12,000 87,500 D
Loading xslF345X05/primarydocument.xml…